Condition: Prostate Cancer · Sponsor: Jules Bordet Institute
This is a a randomized phase II/III trial comparing salvage SBRT with standard of care (SOC) regimens for patients with a persistent detectable PSA or biochemical progression during follow-up after radical prostatectomy.
This description comes directly from the study's public registry record.
Robbe Van den Begin, MD, PhD · +3225413832 · robbe.vandenbegin@hubruxelles.be
Always discuss trial participation with your own doctor first.
| AZorg | Aalst, Belgium | Recruiting |
| Ziekenhuis Aan de Stroom (ZAS) | Antwerp, Belgium | Recruiting |
| AZ Sint Jan | Bruges, Belgium | Recruiting |
| Jules Bordet Institute, H.U.B | Brussels, Belgium | Recruiting |
| Ziekenhuis Oost-Limburg (ZOL) Campus Sint-Jan | Genk, Belgium | Recruiting |
| UZ Gent | Ghent, Belgium | Recruiting |
| Jessa Ziekenhuis | Hasselt, Belgium | Recruiting |
| AZ Groeninge | Kortrijk, Belgium | Recruiting |
| CHU HELORA - Hôpital de La Louvière - site Jolimont | La Louvière, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| AZ Sint-Maarten | Mechelen, Belgium | Recruiting |
| CHU UCL Namur - Site Elisabeth | Namur, Belgium | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06523634